Prof Christopher Little

Related Grants and Projects

• Principal investigator of ARC, a newly identified regulator of chondrocyte differentiation and death, is a novel therapeutic target for OA (funded by National Health and Medical Research Council)
• Participant in microRNAs as therapeutic targets for osteoarthritis (funded by National Health and Medical Research Council)